EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Measuring the Impact: MRI Response of Sacroiliac Joints to TNF Inhibitors in Youth with Axial Disease

Timothy G Brandon iD, Rui Xiao, Daniel J Lovell iD, Edward Oberle iD, Matthew L Stoll iD, Nancy A Chauvin, Michael L Francavilla iD, Walter P Maksymowych iD, Pamela F Weiss iD

Arthritis & Rheumatology · 2025

DOI: 10.1002/art.70050 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Arthritis & Rheumatology, 2025. Verfasst von Timothy G Brandon und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Rheumatology and Clinical Futures, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. Hauptthemen laut MEDLINE: Sacroiliac Joint, Tumor Necrosis Factor-alpha, Antirheumatic Agents, Tumor Necrosis Factor Inhibitors. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate the timeline for resolution of sacroiliac joint (SIJ) inflammation, changes in structural lesions, and their correlation with patient‐reported outcomes in youth with axial juvenile spondyloarthritis (axJSpA) initiating TNF inhibitor (TNFi).

Methods

This prospective, multicenter study included youth aged 8–18 with a clinical diagnosis of axJSpA starting TNFi. Assessments were conducted at baseline and 12 weeks, including clinical evaluation, MRI, and patient‐reported outcomes. Participants with persistent SIJ inflammation at 12 weeks were reassessed at 24 weeks. Three blinded reviewers evaluated MRIs using SPARCC inflammation (SIS) and structural (SSS) scores.

Results

Of 75 enrolled participants, 73 completed baseline visits, and 62 had MRI‐confirmed axJSpA. Fifty‐seven completed a 12‐week follow‐up; 89% (51/57) showed SIS improvement, and 63% (36/57) achieved inflammation resolution (SIS

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sacroiliac JointTumor Necrosis Factor-alphaAntirheumatic AgentsTumor Necrosis Factor InhibitorsHumansFemaleAdolescentMagnetic Resonance ImagingChildProspective StudiesMalePatient Reported Outcome MeasuresTreatment OutcomeInfliximabEtanerceptAdalimumab

Substanzen

Tumor Necrosis Factor-alphaAntirheumatic AgentsTumor Necrosis Factor InhibitorsInfliximabEtanerceptAdalimumab

Autor:innen und Institutionen

  • Department of Pediatrics, Division of Rheumatology and Clinical Futures, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
  • Division of Rheumatology, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio.
  • Department of Pediatrics, Division of Rheumatology, Nationwide Children's Hospital and The Ohio State University, Columbus, Ohio.
  • Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama.
  • The Imaging Institute, The Cleveland Clinic, Cleveland, Ohio.

ORCID-Profile: Timothy G Brandon, Daniel J Lovell, Edward Oberle, Matthew L Stoll, Michael L Francavilla, Walter P Maksymowych, Pamela F Weiss

Förderung

  • NIAMS NIH HHS

Zitieren

APA

Brandon, T. G., Xiao, R., Lovell, D. J., Oberle, E., Stoll, M. L., Chauvin, N. A., Francavilla, M. L., Maksymowych, W. P., & Weiss, P. F. (2025). Measuring the Impact: MRI Response of Sacroiliac Joints to TNF Inhibitors in Youth with Axial Disease. Arthritis & Rheumatology. https://doi.org/10.1002/art.70050

Vancouver

Brandon TG, Xiao R, Lovell DJ, Oberle E, Stoll ML, Chauvin NA, et al. Measuring the Impact: MRI Response of Sacroiliac Joints to TNF Inhibitors in Youth with Axial Disease. Arthritis & Rheumatology. 2025. doi:10.1002/art.70050

BibTeX
@article{Brandon2025,
  author = {Brandon, Timothy G and Xiao, Rui and Lovell, Daniel J and Oberle, Edward and Stoll, Matthew L and Chauvin, Nancy A and Francavilla, Michael L and Maksymowych, Walter P and Weiss, Pamela F},
  title = {Measuring the Impact: MRI Response of Sacroiliac Joints to TNF Inhibitors in Youth with Axial Disease},
  journal = {Arthritis & Rheumatology},
  year = {2025},
  doi = {10.1002/art.70050}
}
Kostenlos starten →